Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOVER HEALTH INVESTMENTS, CORP. /DECLOV · Entity 4419 | CEO, Medicare Advantage | October 07, 2026 | October 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOVER HEALTH INVESTMENTS, CORP. /DE
Report date October 07, 2026 · Filed October 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 2,792,690 |
Reported balance
After 2026-10-07 transaction · row 1
1 source rowRow 1 · 2026-10-07 · Sale · Disposed 2,006 · Balance 2,792,690 F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.54 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.
F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.54 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 07, 2025 Filed Jan 10, 2025 21:10 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 17,142 | $3.60 | $61,711.20 |
DisclosureSEC source: 0001801170-25-000024 · wk-form4_1736543420.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,307,254 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 7, 2025, due to the vesting of the final 25% of the original number of restricted stock units ("RSUs") granted to the Reporting Person on July 16, 2021, and timely reported on a Form 4 filed on July 20, 2021. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 21:12 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 8,149 | $3.29 | $26,810.21 |
DisclosureSEC source: 0001801170-25-000005 · wk-form4_1736284350.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,324,396 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 3, 2025, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| December 15, 2024 Filed Dec 17, 2024 21:17 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 8,691 | $3.11 | $27,029.01 |
DisclosureSEC source: 0001801170-24-000248 · wk-form4_1734470222.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,332,545 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| December 14, 2024 Filed Dec 17, 2024 21:17 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 12,567 | $3.11 | $39,083.37 |
DisclosureSEC source: 0001801170-24-000248 · wk-form4_1734470222.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,341,236 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 31, 2024 Filed Nov 4, 2024 22:40 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 118,050 | $4.12 | $486,366.00 |
DisclosureSEC source: 0001801170-24-000225 · wk-form4_1730760036.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,353,803 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 31, 2024, of 50% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in four equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:17 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 726,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-24-000214 · wk-form4_1729196216.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,471,853 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of October 15, 2024, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of October 15, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 15, 2028. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 20:39 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 8,706 | $4.00 | $34,824.00 |
DisclosureSEC source: 0001801170-24-000200 · wk-form4_1728333576.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,745,739 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 3, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 20:06 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 8,691 | $2.99 | $25,986.09 |
DisclosureSEC source: 0001801170-24-000190 · wk-form4_1726603594.xml · nonDerivative · entry 4 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,754,445 F4 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 15, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022, and originally reported on a Form 4 filed on September 20, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on September 16, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| September 14, 2024 Filed Sep 17, 2024 20:06 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 12,567 | $2.99 | $37,575.33 |
DisclosureSEC source: 0001801170-24-000190 · wk-form4_1726603594.xml · nonDerivative · entry 3 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,763,136 F3 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 14, 2024, of 6.25% of RSUs granted to the Reporting Person on March 14, 2022, and originally reported on a Form 4 filed on March 16, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on March 14, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:06 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 101,917 | $2.99 | $304,731.83 |
DisclosureSEC source: 0001801170-24-000190 · wk-form4_1726603594.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,775,703 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/2 of the number of earned performance-based restricted stock units, as described above. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:06 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 259,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-24-000190 · wk-form4_1726603594.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,877,620 F1 · shares: Represents restricted stock units ("RSUs"), each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units will vest on October 31, 2025, subject to the Reporting Person's continued employment on such vesting date. Read SEC document |
| September 13, 2024 Filed Sep 16, 2025 21:00 UTC Amendment | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 518,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001839066-25-000007 · wk-form4a_1758056426.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,531,545 F1 · shares: Represents restricted stock units ("RSUs"), each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units will vest on October 31, 2025, subject to the Reporting Person's continued employment on such vesting date. This Amendment is being filed solely to reflect the full number of RSUs that were achieved. F2 · balance_after: Number reflects total directly held Class A Common Stock taking into account the amended number and subsequent transactions through September 15, 2024. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 20:07 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 5,388 | $1.25 | $6,735.00 |
DisclosureSEC source: 0001801170-24-000149 · wk-form4_1720469246.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,618,620 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on July 3, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:27 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 52,967 | $1.23 | $65,149.41 |
DisclosureSEC source: 0001801170-24-000145 · wk-form4_1719952056.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,624,008 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/3 of the number of earned restricted stock units, as described above. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:27 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 217,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-24-000145 · wk-form4_1719952056.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,676,975 F1 · shares: Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested and were settled on June 30, 2024, and the remaining one-third of the restricted stock units will vest on June 30, 2025, subject to the Reporting Person's continued employment on such vesting date. Read SEC document |
| June 30, 2024 Filed Sep 16, 2025 20:59 UTC Amendment | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 52,967 | $1.23 | $65,149.41 |
DisclosureSEC source: 0001839066-25-000006 · wk-form4a_1758056396.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,401,108 F1 · shares: This Form 4/A is being filed to solely to clarify that the total number of restricted stock units (RSUs) received upon determination of the level of performance-based RSU grant was previously reported by the Reporting Person on a Form 4/A, filed on January 3, 2024, as described in Footnote 2 below. F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the second tranche of the number of earned restricted stock units, as described herein. Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested on September 7, 2023, one-third of the number of earned restricted stock units vested on June 30, 2024, and the remaining one-third of the earned restricted stock units vested on June 30, 2025. F3 · balance_after: Number reflects total directly held Class A Common Stock taking into account the amended number and transactions through June 30, 2024. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:59 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 5,378 | $1.09 | $5,862.02 |
DisclosureSEC source: 0001801170-24-000129 · wk-form4_1718744338.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,454,075 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 15, 2024, of 6.25% of the original number of RSUs granted to the Reporting Person on on September 16, 2022, and timely reported on a Form 4 filed on September 20, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 20:59 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 7,776 | $1.09 | $8,475.84 |
DisclosureSEC source: 0001801170-24-000129 · wk-form4_1718744338.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,459,453 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 14, 2024, of 6.25% of the original number of RSUs granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 20:18 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 5,387 | $0.76 | $4,094.12 |
DisclosureSEC source: 0001801170-24-000086 · wk-form4_1712348291.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,467,229 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on April 3, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:12 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 5,378 | $0.80 | $4,302.40 |
DisclosureSEC source: 0001801170-24-000075 · wk-form4_1710879131.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,472,616 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2024, of 6.25% of the original number of RSUs granted to the Reporting Person on September 16, 2022, and timely reported on a Form 4 filed on September 20, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 20:33 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 7,777 | $0.73 | $5,677.21 |
DisclosureSEC source: 0001801170-24-000069 · wk-form4_1710793997.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,477,994 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2024, of 6.25% of the original number of RSUs granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 07, 2024 Filed Jan 9, 2024 21:02 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 16,369 | $0.95 | $15,550.55 |
DisclosureSEC source: 0001801170-24-000037 · wk-form4_1704834129.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,485,771 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 7, 2024, due to the vesting of 25% of the original number of restricted stock units ("RSUs") granted to the Reporting Person on July 16, 2021, and timely reported on a Form 4 filed on July 20, 2021. The remaining RSUs will vest on January 7, 2025, subject to the continued service of the Reporting Person on such date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:07 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 26,240 | $0.92 | $24,140.80 |
DisclosureSEC source: 0001801170-24-000022 · wk-form4_1704488797.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,502,140 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 3, 2024, of twenty-five percent of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after January 3, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:33 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 1,559 | $0.95 | $1,481.05 |
DisclosureSEC source: 0001801170-24-000013 · wk-form4_1704317601.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,528,380 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 1, 2024, of the last third of the number of restricted stock units (RSUs) granted to the Reporting Person on January 31, 2022, upon the achievement of certain performance criteria underlying a performance-based RSU award that was granted on July 16, 2021. F2 · balance_after: Amount of securities beneficially owned reflects the amount in the Form 4/A filed on January 3, 2024. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 22:09 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 8,691 | $0.99 | $8,604.09 |
DisclosureSEC source: 0001801170-23-000123 · wk-form4_1703023779.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,529,825 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2023, of 6.25% of the original number of RSUs granted to the Reporting Person on September 16, 2022, and timely reported on a Form 4 filed on September 20, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:51 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 12,567 | $1.00 | $12,567.00 |
DisclosureSEC source: 0001801170-23-000118 · wk-form4_1702936289.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,538,516 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 31, 2023 Filed Nov 2, 2023 20:41 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-23-000090 · wk-form4_1698957676.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,551,083 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Fifty percent of the RSUs will vest on the first anniversary of October 31, 2023, and the remaining RSUs will vest in four equal quarterly installments beginning on the date that is three months after the first anniversary of October 31, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 31, 2025. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 21:19 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 21,511 | $1.13 | $24,307.43 |
DisclosureSEC source: 0000895345-23-000533 · form4.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,951,083 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 15, 2023, of 25% of the original number of RSUs granted to the Reporting Person on September 16, 2022, and timely reported on a Form 4 filed on September 20, 2022. The remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after September 15, 2023, in each case subject to the continued service of the Reporting Person on such vesting date. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 21:19 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 7,776 | $1.13 | $8,786.88 |
DisclosureSEC source: 0000895345-23-000533 · form4.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,972,594 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on September 14, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| September 07, 2023 Filed Sep 11, 2023 20:11 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 52,967 | $1.31 | $69,386.77 |
DisclosureSEC source: 0000895345-23-000530 · form4.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,980,370 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of 1/3 of the number of earned restricted stock units, as described above. Read SEC document |
| September 07, 2023 Filed Sep 11, 2023 20:11 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 652,452 | $0.00 | $0.00 |
DisclosureSEC source: 0000895345-23-000530 · form4.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,033,337 F1 · shares: Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested and was settled on September 7, 2023, and 1/3 of the number of earned restricted stock units will vest on each of June 30, 2024 and June 30, 2025, subject to the reporting person's continued employment through each vesting date. Read SEC document |
| September 07, 2023 Filed Jan 3, 2024 21:30 UTC Amendment | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 652,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-24-000012 · wk-form4a_1704317375.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,033,451 F1 · shares: This Form 4/A is being filed solely to correct the number of restricted stock units (RSUs) received upon determination of the level of performance, as described in Footnote 2 below. F2 · shares: Represents RSUs, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned RSUs vested and were settled on September 7, 2023, and one-third of the number of earned RSUs will vest on each of June 30, 2024, and June 30, 2025, subject to the Reporting Person's continued employment through each vesting date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 20:04 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 7,776 | $0.94 | $7,309.44 |
DisclosureSEC source: 0000895345-23-000392 · form4.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,380,885 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 16, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 16, 2022. The remaining RSUs will vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 17, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| March 14, 2023 Filed Apr 27, 2023 01:50 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 31,455 | $0.93 | $29,253.15 |
DisclosureSEC source: 0000895345-23-000252 · form4.xml · nonDerivative · entry 4 Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,388,661 F4 · shares: Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting, on March 14, 2023, of 25% of the original number of RSUs granted to the Reporting Person on March 14, 2022. The remaining RSUs vest in twelve equal quarterly installments beginning on the date that is three months after March 14, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date. The original grant of RSUs was timely reported on a Form 4 filed on Mach 16, 2022. Read SEC document |
| January 31, 2023 Filed Apr 27, 2023 01:50 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 1,281 | $1.33 | $1,703.73 |
DisclosureSEC source: 0000895345-23-000252 · form4.xml · nonDerivative · entry 3 Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,420,116 F3 · shares: Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting of 1/3rd, of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on January 31, 2022 upon the achievement of certain performance criteria. The original grant was timely reported on a Form 4 filed on July 20, 2021. Read SEC document |
| January 07, 2023 Filed Apr 27, 2023 01:50 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 16,369 | $1.01 | $16,532.69 |
DisclosureSEC source: 0000895345-23-000252 · form4.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,421,397 F1 · shares: Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 16, 2021, on each of January 7, 2022 and January 7, 2023. The original grant was timely reported on a Form 4 filed on July 20, 2021. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:24 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 353,982 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000460 · wf-form4_167295383214450.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,454,877 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of January 3, 2023, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of January 3, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 20:39 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 353,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-025244 · wf-form4_166370634567239.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100,895 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of September 16, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of September 16, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 22:23 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 510,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-006439 · wf-form4_164746936511138.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 747,539 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of March 14, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of March 14, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 23:55 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 15,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-001707 · wf-form4_164384610584079.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,591 F1 · shares: Represents shares of Class A common stock underlying time-based restricted stock units ("RSUs") that vest in three equal annual installments on January 31, 2022, January 1, 2023 and January 1, 2024. On July 16, 2021, the Reporting Person was granted a performance-based restricted stock unit award, and on January 31, 2022, the Talent and Compensation Committee of the Board of Directors certified the achievement of certain of the performance criteria, resulting in the grant of the RSUs. Read SEC document |
| January 31, 2022 Filed Apr 27, 2023 01:56 UTC Amendment | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 1,281 | $2.58 | $3,304.98 |
DisclosureSEC source: 0000895345-23-000255 · form4.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,310 F1 · security: This Form 4/A, amends the original Form 4, filed on February 2, 2022, solely to report the number of shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting, on January 31, 2022, of 1/3rd of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on January 31, 2022 upon the achievement of certain performance criteria. The RSUs vest in equal installments on January 31, 2022, January 1, 2023 and January 1, 2024. F2 · shares: The original Form 4 inadvertently omitted the 1,281 shares that were withheld in connection with the January 31, 2022 vesting event. Read SEC document |
| January 07, 2022 Filed Apr 27, 2023 01:50 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | Tax withholdingClass A Common Stock | 15,830 | $3.16 | $50,022.80 |
DisclosureSEC source: 0000895345-23-000252 · form4.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO of Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,437,766 F1 · shares: Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 16, 2021, on each of January 7, 2022 and January 7, 2023. The original grant was timely reported on a Form 4 filed on July 20, 2021. F2 · balance_after: The number of shares of the Issuer's Class A Common Stock reported as beneficially owned includes an adjustment from the most recent Form 4 filing to reflect 1,281 shares of the Issuer's Class A Common Stock withheld by the Issuer to cover the Reporting Person's tax obligations in connection with a prior vesting event that was reported on a Form 4/A filed on the same date as this Form 4 report. Read SEC document |
| July 16, 2021 Filed Jul 21, 2021 01:50 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 220,820 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-029107 · doc4.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,820 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in equal annual installments over four years, beginning on January 7, 2022, subject to the continuous service of the Reporting Person on each vesting date. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:15 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantStock Options (right to buy) · Derivative | 465,316 | Not disclosed Strike: $4.67 | Not disclosed |
DisclosureSEC source: 0001209191-21-003163 · doc4.xml · derivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 465,316 Underlying: Class B Common Stock · 465,316 shares Expires 2030-07-26 F5 · price: Received in connection with the Business Combination in exchange for options to acquire 225,000 shares of common stock of Legacy Clover for $9.66 per share. F4 · derivative.exercise_date: 100% of the stock option is immediately exercisable. The stock option vests as to 1/5th of the total number of shares on July 27, 2021 and 1/60th of the total number of shares in equal monthly installments thereafter, subject to the continuous service of the Reporting Person on each vesting date. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 02:15 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantStock Options (right to buy) · Derivative | 51,701 | Not disclosed Strike: $3.66 | Not disclosed |
DisclosureSEC source: 0001209191-21-003163 · doc4.xml · derivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,701 Underlying: Class B Common Stock · 51,701 shares Expires 2030-06-28 F3 · price: Received in connection with the Issuer's business combination (the "Business Combination") with Clover Health Investments, Corp. ("Legacy Clover") in accordance with the terms of the Agreement and Plan of Merger dated as of October 5, 2020, among the Issuer (f/k/a Social Capital Hedosophia Holdings Corp. III), Asclepius Merger Sub Inc., and Legacy Clover, as amended by that certain Amendment to the Agreement and Plan of Merger, dated as of December 8, 2020, in exchange for options to acquire 25,000 shares of common stock of Legacy Clover for $7.57 per share. F1 · derivative.exercise_date: 100% of the stock option is immediately exercisable. The stock option vests as to 1/5th of the total number of shares on June 8, 2021 and 1/60th of the total number of shares in equal monthly installments thereafter, subject to the continuous service of the Reporting Person on each vesting date. F2 · derivative.underlying: The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.